Artificial Pancreas Technology Offers Hope for Childhood Diabetes
- 7 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Current Nutrition Reports
- Vol. 10 (1), 47-57
- https://doi.org/10.1007/s13668-020-00347-9
Abstract
Purpose of Review Here, we provide a review of recent advancements in closed-loop or automated insulin delivery systems commonly referred to as the “artificial pancreas” (AP) for the management of type 1 diabetes (T1D). Recent Findings The use of hybrid closed-loop devices in children and adolescents with T1D consistently increases time in the target glucose range (70–180 mg/dL) without increasing the risk of hypoglycemia. Although hybrid closed-loop systems are able to maintain fairly tight glycemic control overnight, daytime control remains challenging, primarily due to meals and exercise, and careful carbohydrate counting and meal boluses remain essential components of optimal diabetes control. Bihormonal and fully automated AP systems remain investigational at this time. Summary While commercially available hybrid closed-loop AP systems improve glycemic control in children with T1D, more work is needed to achieve a fully automated AP system and decrease the burden of using diabetes technology.Keywords
This publication has 65 references indexed in Scilit:
- Multinational Home Use of Closed-Loop Control Is Safe and EffectiveDiabetes Care, 2016
- Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trialThe Lancet Diabetes & Endocrinology, 2016
- PsychDT Working GroupJournal of Diabetes Science and Technology, 2015
- Retrospective Analysis of the Real-World Use of the Threshold Suspend Feature of Sensor-Augmented Insulin PumpsDiabetes Technology & Therapeutics, 2015
- Assessing Sensor Accuracy for Non-Adjunct Use of Continuous Glucose MonitoringDiabetes Technology & Therapeutics, 2015
- Outpatient Glycemic Control with a Bionic Pancreas in Type 1 DiabetesThe New England Journal of Medicine, 2014
- Closed-Loop Artificial Pancreas Systems: Engineering the AlgorithmsDiabetes Care, 2014
- Threshold-Based Insulin-Pump Interruption for Reduction of HypoglycemiaThe New England Journal of Medicine, 2013
- Fully Automated Closed-Loop Insulin Delivery Versus Semiautomated Hybrid Control in Pediatric Patients With Type 1 Diabetes Using an Artificial PancreasDiabetes Care, 2008
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusThe New England Journal of Medicine, 1993